Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for ATXI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 0.569M
March 31, 2026 1.198M
December 31, 2025 1.832M
September 30, 2025 3.557M
June 30, 2025 4.058M
March 31, 2025 3.51M
December 31, 2024 2.797M
September 30, 2024 2.61M
June 30, 2024 4.764M
March 31, 2024 2.836M
December 31, 2023 1.582M
September 30, 2023 -3.65M
June 30, 2023 -5.336M
March 31, 2023 -1.452M
December 31, 2022 3.905M
September 30, 2022 -0.039M
June 30, 2022 0.598M
March 31, 2022 1.159M
December 31, 2021 3.451M
Date Value
September 30, 2021 -0.16M
June 30, 2021 0.642M
March 31, 2021 1.475M
December 31, 2020 2.359M
September 30, 2020 3.234M
June 30, 2020 4.101M
March 31, 2020 5.773M
December 31, 2019 6.80M
September 30, 2019 11.96M
June 30, 2019 13.90M
March 31, 2019 20.35M
December 31, 2018 -0.631M
September 30, 2018 2.794M
June 30, 2018 5.017M
March 31, 2018 9.353M
December 31, 2017 19.38M
September 30, 2017 24.19M
June 30, 2017 27.16M
March 31, 2017 -8.904M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 597.21M
Corcept Therapeutics, Inc. 705.78M
Veru, Inc. 28.38M
Johnson & Johnson 84.97B
Eli Lilly & Co. 33.88B

Shareholders Equity (Quarterly) Related Metrics